NOV
43
4
NDAQ
70
3
CHD
34
3
MRK
41
-2
PEP
60
21
GE
71
-6
SYF
76
2
HAL
50
4
EXPE
58
5
AIG
51
-3
UHS
44
2
AIV
47
-4
DIS
64
6
NWL
44
3
DVN
36
3
NWS
78
4
RRC
46
3
FLR
68
12
BA
40
-2
VRSN
53
-2
NOV
43
4
NDAQ
70
3
CHD
34
3
MRK
41
-2
PEP
60
21
GE
71
-6
SYF
76
2
HAL
50
4
EXPE
58
5
AIG
51
-3
UHS
44
2
AIV
47
-4
DIS
64
6
NWL
44
3
DVN
36
3
NWS
78
4
RRC
46
3
FLR
68
12
BA
40
-2
VRSN
53
-2
Financhill
Back

UroGen Pharma Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62

URGN
UroGen Pharma

Last Price:
$15.12
Seasonality Move:
0.45%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

UroGen Pharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 14.34 Buy
20-day SMA: 13.97 Buy
50-day SMA: 10.24 Buy
200-day SMA: 11 Buy
8-day EMA: 12.59 Buy
20-day EMA: 7.94 Buy
50-day EMA: 3.94 Buy
200-day EMA: 1.1 Buy

UroGen Pharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.05 Buy
Relative Strength Index (14 RSI): 68.18 Buy
Chaikin Money Flow: 1717720 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.95 - 15.03) Buy
Bollinger Bands (100): (7.61 - 13.21) Buy

UroGen Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for UroGen Pharma Stock

Is UroGen Pharma Stock a Buy?

  • UroGen Pharma share price is 15.41 while URGN 8-day simple moving average is 14.34, which is a Buy signal.
  • The stock price of URGN is 15.41 while UroGen Pharma 20-day SMA is 13.97, which makes it a Buy.
  • UroGen Pharma 50-day simple moving average is 10.24 while URGN share price is 15.41, making it a Buy technically.
  • URGN stock price is 15.41 and UroGen Pharma 200-day simple moving average is 11.00, creating a Buy signal.

URGN Technical Analysis vs Fundamental Analysis

Buy
62
UroGen Pharma (URGN) is a Buy

Is UroGen Pharma a Buy or a Sell?

  • UroGen Pharma stock is rated a Buy
    The current UroGen Pharma [URGN] share price is $15.41. The Score for URGN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.

UroGen Pharma Stock Info

Market Cap:
710.5M
Price in USD:
15.41
Share Volume:
2M

UroGen Pharma 52-Week Range

52-Week High:
17.00
52-Week Low:
3.42
Buy
62
UroGen Pharma (URGN) is a Buy

UroGen Pharma Share Price Forecast

  • What is the UroGen Pharma stock price today?
    The UroGen Pharma stock price is 15.41 USD today.
  • Will URGN stock go up or go down?
    UroGen Pharma> share price is forecast to RISE/FALL based on technical indicators
  • Is UroGen Pharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, UroGen Pharma is not overvalued.

Is UroGen Pharma Stock a Buy?

  • UroGen Pharma share price is 15.41 while URGN 8-day exponential moving average is 12.59, which is a Buy signal.
  • The stock price of URGN is 15.41 while UroGen Pharma 20-day EMA is 7.94, which makes it a Buy.
  • UroGen Pharma 50-day exponential moving average is 3.94 while URGN share price is 15.41, making it a Buy technically.
  • URGN stock price is 15.41 and UroGen Pharma 200-day simple moving average is 1.10, creating a Buy signal.

Fundamental Analysis of UroGen Pharma

Is UroGen Pharma a good investment?

  • Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.22 per share, an increase this year of $0.25 per share, and an increase next year of $1.85 per share.

Technical Analysis of UroGen Pharma

Should I short UroGen Pharma stock?

* UroGen Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.